CLL Society News Archives

December 29, 2022

What Makes Being Diagnosed with CLL So Surprising

Dr. Koffman was interviewed by Prevention magazine to share some of his emotional experiences when he was diagnosed with chronic lymphocytic leukemia in 2005 and what he learned that helped him cope, primarily through the early part of his journey when he was asked to “Watch and Wait.” The

December 29, 2022

EAT THIS, NOT THAT! Signs There May Be Something Wrong with Your Blood, Including Weight Loss

While the questions were about blood disorders in general and not chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) or even leukemias specifically, you might find my responses and those of Dr. Eric Tam helpful in developing a broader understanding of what can go wrong in blood cancers and other disorders.

November 22, 2022

Dr. Susan O’Brien Named a Top Female Scientist in 2022

Dr. Susan O’Brien was recognized as one of the top 40 female scientists in the world in 2022. We are proud to have Dr. O’Brien as a member of CLL Society’s Board of Directors.

November 14, 2022

Many Patients with Weak Immune Systems Don’t Realize Their COVID-19 Medicine Isn’t as Effective as It Used to Be

CNN interviewed CLL Society’s Dr. Brian Koffman and Robyn Brumble, RN, among others, to gain perspective on the significance of the diminishing susceptibility of the emerging SARS-CoV-2 Variants of Concern (VOC) to Evusheld, the only Pre-Exposure Prophylaxis (PrEP) for the immunocompromised; including all those with chronic lymphocytic leukemia/small lymphocytic

October 3, 2022

CLL Society Sends a Comment Letter to the Centers for Medicare and Medicaid Services

The National Institutes of Health (NIH) Now Recognize those with CLL/SLL as Being Immunocompromised, Regardless of Treatment Status

August 26, 2022

Dr. Brian Koffman Shares His Experience Receiving Evusheld with ASPR to Increase Awareness and Access Across Healthcare Practices in the United States

CLL Society believes that every immunocompromised individual, including those with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), regardless of treatment status, should experience easy access to the life-saving pre-exposure prophylaxis therapy or PreP, Evusheld.

August 25, 2022

We Need Your Help: The FDA Will Be Reviewing Whether Duvelisib Should Be Withdrawn or Continue to be Approved for Relapsed/Refractory CLL

CLL Society would like to make a special request to all of those who have CLL/SLL in our community to please consider submitting a personal comment to the FDA regarding the possibility of duvelisib being removed as an available treatment option.

August 19, 2022

Announcing the Winner of CLL Society’s First Ever Young Investigator Research Program Award: Dr. Christine Ryan on the Topic of Richter’s Syndrome

In January 2022, CLL Society formally announced the launch of a new Research Program that is devoted to supporting underfunded areas of bench and translational science to make progress in the following four critical areas of unmet needs for those diagnosed with CLL/SLL:

August 15, 2022

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

CLL Society News

What Makes Being Diagnosed with CLL So Surprising

EAT THIS, NOT THAT! Signs There May Be Something Wrong with Your Blood, Including Weight Loss

Dr. Susan O’Brien Named a Top Female Scientist in 2022

Many Patients with Weak Immune Systems Don’t Realize Their COVID-19 Medicine Isn’t as Effective as It Used to Be

CLL Society Sends a Comment Letter to the Centers for Medicare and Medicaid Services

Dr. Brian Koffman Shares His Experience Receiving Evusheld with ASPR to Increase Awareness and Access Across Healthcare Practices in the United States

We Need Your Help: The FDA Will Be Reviewing Whether Duvelisib Should Be Withdrawn or Continue to be Approved for Relapsed/Refractory CLL

Announcing the Winner of CLL Society’s First Ever Young Investigator Research Program Award: Dr. Christine Ryan on the Topic of Richter’s Syndrome

The National Institutes of Health (NIH) Now Recognize those with CLL/SLL as Being Immunocompromised, Regardless of Treatment Status

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT